Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418022 · ClinicalTrials.gov registry record · NA
Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning
A NA study of Shock and Fluid Overload, sponsored by Lenox Hill Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06418022: Recruiting NA study of Shock and Fluid Overload, sponsored by Lenox Hill Hospital.
NCT06418022 is a NA study of Shock and Fluid Overload that is actively recruiting participants, run by Lenox Hill Hospital. The registered enrollment target is 400 participants, roughly in line with the 437-participant average among 9 other Shock trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06418022, a NA study of Shock and Fluid Overload, is actively recruiting participants, sponsored by Lenox Hill Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Fluid administration is a commonly performed in the ICU for critically ill patients. However, it can lead to complications such as fluid overload, pulmonary edema, and increased mortality in some patients. Therefore, identifying patients who are likely to respond to fluid therapy is crucial for optimizing their management. Several methods have been used to assess fluid responsiveness, such as passive leg raising, stroke volume variation, and cardiac output monitoring. However, these methods have limitations and may not be feasible in all patients. In this study, the investigators aim to evaluate the use of velocity time integral (VTI) and Trendelenburg positioning in predicting fluid responsiveness in ICU patients.
Conditions Studied
Interventions
- DEVICE Trendelenburg positioning VTI
Study Locations (1)
New York
- Lenox Hill Hospital- Northwell Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
What NCT06418022 shows while recruiting
NCT06418022 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 437-participant average among 9 other Shock trials with a reported enrollment target.
The record links to 3 conditions, with Shock appearing as the primary indexed condition, and to 1 intervention - of which Trendelenburg positioning VTI is the first listed.
NCT06418022 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06418022 about?
NCT06418022 is a clinical study titled "Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning". Fluid administration is a commonly performed in the ICU for critically ill patients. However, it can lead to complications such as fluid overload, pulmonary edema, and increased mortality in some patients. Therefore, identifying patients who are likely to respond to fluid therapy is crucial for opti...
What is the current status of trial NCT06418022?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-04-01. Estimated completion is 2025-08-01.
What conditions does trial NCT06418022 study?
This clinical trial studies the following conditions: Shock, Fluid Overload, Cardiac Output, Low.
What interventions are being tested in trial NCT06418022?
The interventions under investigation include: Trendelenburg positioning VTI (DEVICE).
Who is sponsoring clinical trial NCT06418022?
This trial is sponsored by Lenox Hill Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06418022 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06418022's enrollment target sits among peer trials
400 4th of 9 higher than 6 of 9 other Shock trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shock trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Central Line Study
RECRUITING · Phase 4
-
Vasoactive Drugs in Intensive Care Unit
RECRUITING · Phase 4
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI